Through 20+ insurer partners, Virta’s treatment is now available to 1000+ new organizations and 5M+ covered lives via employer group partnerships
SAN FRANCISCO (December 14, 2021)—Today Virta Health, the leader in type 2 diabetes reversal, announced it now works with more than 20 national and regional health plans, marking 133% year-over-year growth with large insurer customers. Of these partners, nearly half—including Humana and Providence Health Plan—now offer Virta’s diabetes reversal treatment to their self-funded employer groups, representing thousands of companies and over 5M covered lives.
Heightened demand for Virta coincides with an industry-wide shift towards reversal as an antidote to America’s worsening metabolic disease epidemic. Virta’s clinically-proven treatment upends traditional approaches, and helps patients normalize blood sugar while removing the need for expensive medications like insulin. Recent analysis demonstrated payer savings of $425 per Virta patient per month, or $10,000 over the first two years.
“The tide is turning towards disease reversal as the primary goal for type 2 diabetes treatment,” said Sami Inkinen, CEO and co-founder of Virta. “Our accelerating health plan growth affirms this shift, as payers race to cut costs while helping patients transform their health.”
Recognizing this transition, the American Diabetes Association, the Endocrine Society, the European Association for the Study of Diabetes, and Diabetes UK recently released a consensus report that defined diabetes reversal for the first time while refining remission criteria.
Alongside health plan growth, Virta is also rapidly expanding its reach with employer customers. Over the last year alone, Virta has seen triple digit year-over-year growth for its enterprise business.
To learn more about how Virta’s diabetes reversal offering can save money and improve the health of your population, reach out to partner@virtahealth.com.
.jpg)
